E. C. Houdijk

New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial

J. Rotteveel, A. Hokken-Koelega, R. Odink, 2015, Clinical endocrinology.

The effect of family-based multidisciplinary cognitive behavioral treatment on health-related quality of life in childhood obesity

H. Pijl, J. Wit, R. Vos, 2012, Quality of Life Research.

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

J. Wit, J. Rotteveel, A. Hokken-Koelega, 2009, The Journal of clinical endocrinology and metabolism.

Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.

J. Rotteveel, H. van Wieringen, A. Hokken-Koelega, 2013, The Journal of clinical endocrinology and metabolism.

The Predictive Value of the Individual Components of the Metabolic Syndrome for Insulin Resistance in Obese Children

H. Pijl, J. Wit, R. Vos, 2011, Hormone Research in Paediatrics.

Second-tier testing for 21-hydroxylase deficiency in the Netherlands; a newborn screening pilot study.

A. Heijboer, M. Finken, M. Ackermans, 2021, The Journal of clinical endocrinology and metabolism.

Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.

J. Rotteveel, H. van Wieringen, A. Hokken-Koelega, 2015, The Journal of clinical endocrinology and metabolism.